Synaptive Medical Inc., a portfolio company of General Atlantic, has raised CDN $57.32 million from 34 investors (including 18 US investors) led by two large investors, likely two corporate investors, one from The Netherlands investing $19.47 million and one from France investing $10.38 million.
Toronto based Synaptive Medical Inc. is a medical device and technology company. Its integrated BrightMatter™ solutions, which include surgical planning, navigation and visualization, robotics and an integrated informatics platform, are designed and manufactured to give clinicians the information they need to ensure the best possible outcomes for patients.
Synaptive Medical Inc. has raised over $106 million in equity financing since December 2015, not including the undisclosed amount invested by General Atlantic in November 2016. Its investors also included Kite Capital of UK, family offices from Alberta, and Canadian, US and international private investors.
photo credit: Synaptive Medical